August 21, 2015
A District of Columbia federal judge on Friday said that Amgen Inc. can't force a journalist to testify about an article he wrote that was cited in a shareholder class action, ruling that the biotech drug giant failed to adequately pursue alternative sources of information before seeking to depose the journalist.